TE
Tempus AI
TEM·NASDAQChicago ILFounded 20152,500 employees
Mid CapbiotechPublicOncology
Platform: AI Precision Med
Market Cap
$8B
All Drugs
4
Clinical Trials
10
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (TEM)
Loading TEM stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TEM-8322 | TEM-8322 | Preclinical | 2 | IL-23 | PompeAsthma | ||
| TEM-5063 | TEM-5063 | Preclinical | 2 | SGLT2 | T2DAS | ||
| Gozebrutinib | TEM-6828 | Approved | 4 | Tau | CRCWilms | ||
| TEM-4581 | TEM-4581 | Phase 2/3 | 2 | CGRP | MCLNarcolepsy |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (11)